TY - JOUR
T1 - Puumala hantavirus excretion kinetics in bank voles (Myodes glareolus)
AU - Hardestam, Jonas
AU - Karlsson, Malin
AU - Falk, Kerstin I.
AU - Olsson, Gert
AU - Klingström, Jonas
AU - Lundkvist, Åke
PY - 2008
Y1 - 2008
N2 - Puumala hantavirus is present in bank voles (Myodes glareolus) and is believed to be spread mainly by contaminated excretions. In this study, we subcutaneously inoculated 10 bank voles with Puumala virus and sampled excretions until day 133 postinfection. Levels of shed viral RNA peaked within 11-28, 14-21, and 11-28 days postinfection for saliva, urine, and feces, respectively. The latest detection of viral RNA was 84, 44, and 44 days postinfection in saliva, urine, and feces, respectively. In contrast, blood of 5 of 6 animals contained viral RNA at day 133 postinfection, suggesting that bank voles secrete virus only during a limited time of the infection. Intranasal inoculations with bank vole saliva, urine, or feces were all infectious for virus-negative bank voles, indicating that these 3 transmission routes may occur in nature and that rodent saliva might play a role in transmission to humans.
AB - Puumala hantavirus is present in bank voles (Myodes glareolus) and is believed to be spread mainly by contaminated excretions. In this study, we subcutaneously inoculated 10 bank voles with Puumala virus and sampled excretions until day 133 postinfection. Levels of shed viral RNA peaked within 11-28, 14-21, and 11-28 days postinfection for saliva, urine, and feces, respectively. The latest detection of viral RNA was 84, 44, and 44 days postinfection in saliva, urine, and feces, respectively. In contrast, blood of 5 of 6 animals contained viral RNA at day 133 postinfection, suggesting that bank voles secrete virus only during a limited time of the infection. Intranasal inoculations with bank vole saliva, urine, or feces were all infectious for virus-negative bank voles, indicating that these 3 transmission routes may occur in nature and that rodent saliva might play a role in transmission to humans.
UR - https://res.slu.se/id/publ/19511
U2 - 10.3201/eid1408.080221
DO - 10.3201/eid1408.080221
M3 - Journal article
C2 - 18680643
SN - 1080-6040
VL - 14
SP - 1209
EP - 1215
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 8
ER -